STK26 and ovarian cancer: Furthermore, inhibiting miR-4728-3p with a specific anti-miR in breast and ovarian cancer cells that endogenously express moderate to high levels of miR-4728-3p was sufficient to increase MST4 protein levels (Figure 3d).